Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andrade FH, Reid MB, Allen DG, Westerblad H. (1998). Effect of hydrogen peroxide and dithiothreitol on contractile function of single skeletal muscle fibers from mouse. J Phyisiol 509, 565–575.
Appendini L, Purro A, Patessio A, Zanaboni S, Carone M, Spada E, Donner CF, Rossi A. (1996). Partitioning of inspiratory muscle workload and pressure assistance in ventilator-dependent COPD patients. Am J Respir Crit Care Med 154, 1301–1309.
Armstrong RB. (1988). Muscle fiber recruitment patterns and their metabolic correlates. In: Horton HS, Terjung RL, eds. Exercise, nutrition, and energy metabolism. New York: Macmillan Publishing Company, pp 9–26.
Arnason BGW. (1984). Acute inflammatory demyielinating polyradiculoneuropathies. In: Peripheral Neuropathy. Dyck PJ, Thomas PK, Lambert EH and Bunge RP eds. Saunders, pp 2050–2100.
Balagopal P, Schimke JC, Ades P, Adey D, Nair KS. (2001). Age effect on transcript levels and synthesis rate of muscle MHC and response to resistance exercise. Am J Physiol Endocrinol Metabol 2001; 280, E203–E208.
Barnes D, Munro PM, Youl BD, Prineas JW, McDonald WI. (1991). The longstanding MS lesion. A quantitative MRI and electron microscopic study. Brain 114, 1271–1280.
Barreiro E, Gea J, Sanjuás C et al. (1998). Lung volumes and respiratory muscle function before and after exercise in patients with severe asthma. Eur Respir J 1998; 12 (suppl 29), 64s–65s.
Barreiro E, Ferrer A, Hernández-Frutos N, Palacio J, Broquetas J, Gea J. (1999). Expiratory function and cellular properties of the external oblique muscle in patients with extremely severe COPD. Am J Crit Care Med 159 (suppl), A588.
Barreiro E, Comtois AS, Gea J, Laubach VE, Hussain SNA. (2002a). Protein tyrosine nitration in the ventilatory muscles: role of nitric oxide synthases. Am J Respir Cell Mol Biol 26, 438–446.
Barreiro E, Comtois AS, Mohammed S, Lands L, Hussain SNA. (2002b). Role of heme oxygenases in sepsis-induced diaphragmatic contractile dysfunction and oxidative stress. Am J Physiol Lung Cell Mol Physiol 283, L476–L484.
Barreiro E, Gea J, Corominas JM, Hussain SN. (2003). Nitric oxide synthases and protein oxidation in the quadriceps femoris of patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 29, 771–778.
Barreiro E, Gea J, Sanjuas C, Marcos R, Broquetas J, Milic-Emili J. (2004a). Dyspnoea at rest and at the end of different exercises in patients with near-fatal asthma. Eur Respir J 24, 219–225.
Barreiro E, Gea J, Di Falco M, Kriazhev L, James S, Hussain SN. Protein carbonyl formation in the diaphragm. Am J Respir Mol Cell Biol 2005b; 32, 9–17.
Barreiro E, de la Puente B, Minguella J, Corominas JM, Serrano S, Hussain S, Gea J. Oxidative stress and respiratory muscle dysfunction in severe COPD. Am J Respir Crit Care Med 2005 (in press).
Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271 (40), C1424–C1437.
Beller GA. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation. J Nucl Cardiol 1997; 4, S152–S157.
Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R, Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158, 629–634.
Bloomfield SA. Changes in musculoskeletal structure and function with prolonged bed rest. Med Sci Sports Exerc 1997; 29, 197–206.
Boczkowski J, Dureuil B, Pariente R, Aubier M. Preventive effects of indomethacin on diaphragmatic contractile alterations in endotoxemic rats. Am Rev Respir Dis 1990; 142, 193–198.
Boffoli D, Scacco SC, Vergari R, Persio MT, Solarino G, Laforgia R, Papa S. Decline with age of the respiratory chain activity in human skeletal muscle. Biochim Biophys Acta 1994; 1226, 73–82.
Bolton C, Ionescu A, Shiels K et al. Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170, 1286–1293.
Brown LK. Respiratory Dysfunction in Parkinson’s disease. In: Respiratory dysfunction in neuromuscular disease. Clin Chest Med. Fanburg BL and Sicilian L eds. WB Saunders Company. Philadelphia 1994, pp 715–727.
Bruin PF, Ueki J, Watson A, Pride NB.. Size and strenght of the respiratory and quadriceps muscles in patients with chronic asthma. Eur Resp J 1997;10, 59–64.
Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 1996; 15 1753–1765.
Burke JF, Pontoppidan H, Welch CE. High output respiratory failure. Ann Surg 1963; 158, 581–594.
Buskila D, Odes L, Neumann L, Odes H. Fibromyalgia in inflammatory bowel disease. J Rheumatol 1999; 26, 1167–1171.
Callahan LA, Stofan D, Szweda LI, Nethery D, Supinski G. Free radicals alter maximal diaphragmatic mitochondrial oxygen consumption in endotoxin-induced sepsis. Free Radic Biol Med 2001a; 30, 129–138.
Callahan LA, Nethery D, Stofan D, DiMarco A, Supinski G. Free radical-induced contractile protein dysfunction in endotoxin-induced sepsis. Am J Respir Cell Mol Biol 2001b; 24, 210–217.
Campbell JA, Hughes RL, Shagal V, Frederiksen J, Shields TW. Alterations in intercostal muscle morphology and biochemistry in patients with chronic obstructive lung disease. Am Rev Respir Dis 1980; 122, 679–686.
Cano A, Gea J, Roquer J et al. Pulmonary function in previously untreated Parkinson Disease (PD) patients. Effects of apomorphine. Am J Respir Crit Care Med 1996; 153 (suppl), A 22.
Carmeli E, Coleman R, Reznick A. The biochemistry of aging muscle. Exp Gerontol 2002; 37, 477–489.
Carroll SB. Genetics and the making of Homo sapiens. Nature 2003; 422, 849–857.
Casaburi R. Skeletal muscle function in COPD. Chest 2000; 117, 267S–271S.
Casadevall C, Coronell C, Ramrez A, Barreiro E, Orozco-Levi M, Gea J. Local expression of the gene encoding TNF-alpha in the external intercostal and quadriceps muscles of severe COPD patients. Am J Respir Crit Care Med 2003; 167 (suppl), A29.
Chakravarthy MV, Davis BS, Booth FW. IGF-I restores satellite cell proliferative potential in immobilized old skeletal muscle. J Appl Physiol 2000; 89, 1365–1379.
Chen H, Tang Y. Sleep loss impairs inspiratory muscle endurance. Am Rev Respir Dis 1989;140, 907–9.
Chevari S, Andial T, Benke K, Shtrenger IA, Free radical reactions and cancer, Vopr Med Khim 1992; 38, 4–5.
Choi AMK, Alam J. Heme oxygenase-1: Function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol 1996; 15: 9–19.
Chretien D, Gallego J, Barrientos A, Casademont J, Cardellach F, Munnich A, Rotig A, Rustin P. Biochemical parameters for the diagnosis of mitochondrial respiratory chain deficiency in humans, and their lack of age-related changes. Biochem J 1998; 329, 249–254.
Chua TP, Anker SD, Harrington D, Coats AJ. Inspiratory muscle strength is a determinant of maximum oxygen consumption in chronic heart failure. Br Heart J 1995; 74, 381–385.
Civatte M, Bartoli C, Schleinitz N, Chetaille B, Pellissier JF, Figarella-Branger D. Expression of the beta chemokines CCL3, CCL4, CCL5 and their receptors in idiopathic inflammatory myopathies. Neuropathol Appl Neurobiol 2005; 31, 70–79.
Cohen CA, Zagelbaum G, Gross D, Roussos C, Macklem PT. Clinical manifestations of inspiratory muscle fatigue. Am J Med 1982; 73, 308–316.
Coronell C, Orozco-Levi M, Mendez R, Ramirez A, Galdiz JB, Gea J. Relevance of assessing quadriceps endurance in patients with COPD. Eur Respir J 2004; 24, 129–136.
Costelli P, Carbó N, Tessitore L, Bagby GJ, López-Soriano FJ, Argilés JM, Baccino FM. Tumour necrosis factor-alpha mediates changes in muscle protein turnover in a cachectic rat tumour model. J Clin Invest 1993; 92, 2783–2789.
Cotes JE, Zejda J, King B. Lung function impairment as a guide to exercise limitation in work-related lung disorders. Am Rev Respir Dis 1988; 137, 1089–1093.
Criswell DS, Shanely RA, Betters JJ, McKenzie MJ, Sellman JE, Van Gammeren DL, Powers SK. Cumulative effects of aging and mechanical ventilation on in vitro diaphragm function. Chest 2003; 124, 2302–2308.
Decramer M, deBock V, Dom R. Functional and histologic picture of steroid-induced myopathy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 153, 1958–1964.
Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J. 1997; 10, 417–423
Deconinck N, Van Parijs V, Bleeckers-Bleukx G et al. Critical illness myopathy unrelated to corticosteroids or neuromuscular blocking agents. Neuromuscul Disord 1998; 8, 186–192.
DeWys W. Management of cancer cachexia. Semin Oncol 1985; 12, 452–460.
Di Francia M, Barbier D, Mege JL, Orehek J. Tumor necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1994; 150, 1453–1455.
Dick PJ. Diseases of peripheral nerves. In: Myology. Engel AG and Franzini-Armstrong C eds. New York 1994, pp 1870–1904.
Diffee GM, Caiozzo VJ, Herrick RE, Baldwin KM. Contractile and biochemical properties of rat soleus and plantaris after hindlimb suspension. Am J Physiol 1991; 260 (Cell Physiol 29), C528–C534.
Dodd DS, Brancatisano T, Engel LA. Chest wall mechanics during exercise in patients with severe chronic airflow obstruction. Am Rev Respir Dis 1984; 129, 33–38.
Drachman DB. Myasthenia gravis. N Engl J Med 1978; 298, 136–142 and 186–193.
Drexler H, Riede U, Münzel T, König H, Funke E, Just H. Alterations of skeletal muscle in chronic heart failure. Circulation 1992; 85, 1751–1759.
Drexler H. Changes in the peripheral circulation in heart failure. Curr Opin Cardiol 1995; 10, 268–273.
Dudley GA, Terjung RL. Influence of aerobic metabolism on IMP accumulation in fast-twitch muscle. Am J Physiol 1985; 248, C37–C42.
Dunnigan A, Staley NA, Smith SA, et al. Cardiac and skeletal muscle abnormalities in cardiomyopathy: comparison of patients with ventricular tachycardia or congestive heart failure. J Am Coll Cardiol 1987; 10, 608–618.
Engel AG, Lambert EH, Howard FM. Immune complexes (IgG and C3) at the motor end-plate in myasthenia gravis: ultrastructural and light microscopic localization and electrophysiologic correlations. Mayo Clin Proc 1977; 52, 267–280.
Engel AG, Arahata K. Monoclonal antibody analysis of mononuclear cells in myopathies: II. Phenotypes of autoinvasive cells on polymyositis and inclusion body myositis. Ann Neurol 1984; 16, 209–215.
Engel AG, Hohlfeld R, Banker BQ. The polymyositis and dermatomyositis syndromes. In: Myology. Engel AG and Franzini-Armstrong C eds. New York 1994a, pp 1335–1383.
Engel AG. Acquired autoimmune Myasthenia Gravis. In: Myology. Engel AG and Franzini-Armstrong C eds. New York 1994b, pp 1769–1797.
Epstein SK. An Overview on Respiratory Muscle Function, Clin Chest Med, 1994: 15, 619–639.
Essen-Gustavsson B, Henriksson J. Enzyme levels in pools of microdissected human muscle fibres of identified type. Adaptive response to exercise. Acta Physiol Scand 1984; 120, 505–515.
Fang FC. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 100, S43–S50
Fernandez-Sola J, Cusso R, Picado C, Vernet M, Grau JM, Urbano-Marquez A. Patients with chronic glucocorticoid treatment develop changes in muscle glycogen metabolism. J Neurol Sci 1993; 117, 103–106.
Fischman DA, Cerami A, Lowry SF. Cachectin/TNF or IL-1a induces cachexia with redistribution of body proteins. Am J Physiol 1989; 256, R659–R665.
Flores EA, Bristain BR, Pomposelli JJ, Dinarello CA, Blackburn GL, Istfan NW. Infusion of tumor necrosis factor /cachectin promotes muscle metabolism in the rat. J Clin Invest 1989; 83, 1614–1622.
Fong Y, Moldawer LL, Morano M, Wei H, Barber A, Manogue K, Tracey KJ, Kuo G, Garca-Martnez C, Agell N, Llovera M, López-Soriano FJ, Argilés JM. Tumour necrosis factor-alpha increases the ubiquitinization of rat skeletal muscle proteins. FEBS Lett 1993; 323, 211–214.
Foote RA, Kimbrough SM, Stevens JC. Lupus myositis Muscle Nerve 1982, 5, 65–68.
Friman G. Effects of acute infectious disease on isometric strength. Scand J Clin Lab Invest 1977; 37, 303–308.
Garca-Martnez C, Llovera M, Agell N, López-Soriano FJ, Argilés JM. Ubiquitin gene expression in skeletal muscles is increased by tumour necrosis factor-alpha. Biochem Biophys Res Commun 1994; 201, 682–686.
Garca-Martnez C, López-Soriano FJ, Argilés JM. Amino acid uptake in skeletal muscle of rats bearing the Yoshida AH-130 ascites hepatoma. Mol Cell Biochem 1995; 148, 17–23.
Garpestad E, Hatayama H, Parker J et al. Stroke volume and cardiac output decrease at termination of obstructive apneas. J Appl Physiol 1992;73, 1743–8.
Gaston B, Drazen JM, Loscalzo J, Stamler JS. The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149, 538–551.
Gea J. Myosin gene expression in the respiratory muscles. Eur Resp J 1997; 10, 2404–2410.
Gea J, Pastó M, Ennion S, Goldspink G, Broquetas JM. Expression of the genes corresponding to Myosin Heavy Chain isoforms (MyHC I, IIa and IIx) in the diaphragm of patients suffering from COPD. Eur Respir J 1998; 12 (suppl 28), 267 s.
Gea J, Hamid Q, Czaika G, Zhu E, Mohan-Ram V, Goldspink G, Grassino A. Expression of Myosin Heavy Chain isoforms in the respiratory muscles following inspiratory resistive breathing. Am J Respir Crit Care Med 2000; 161, 1274–1278.
Gea J, Orozco-Levi M, Barreiro E, Ferrer A, Broquetas J. Structural and functional changes in the skeletal muscles of COPD patients: The ‘‘Compartments’’ Theory. Mon Arch Chest Dis 2001a, 56, 214–224.
Gea J, Pasto M, Carmona M, Orozco-Levi M, Palomeque J, Broquetas J. Metabolic characteristics of the deltoid muscle in patients with chronic obstructive pulmonary disease. Eur Respir J 2001b; 17, 939–945.
Global Initiative for Asthma. (G.I.N.A) Global Strategy for Asthma Management and Prevention. NHLBI. Bethesda, 2001. www.ginasthma.com.
Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease. NHLBI/WHO workshop report. Bethesda, 2004. National Heart, Lung and Blood Institute. Update of the Management Sections, GOLD website, www.goldcopd.com.
Gnaiger E, Lassnig B, Kuznetsov A, Rieger G, Margreiter R. Mitochondrial oxygen affinity, respiratory flux control and excess capacity of cytochrome c oxidase. J Exp Biol 1998; 201, 1129–1139.
Goldberg A. Goodman H. Relationship between cortisone and muscle work in determining muscle size. J Physiol 1969; 200, 667–75.
Goldman MD, Grassino A, Mead J, Sears A. Mechanics of the human diaphragm during voluntary contraction: Dynamics. J Appl Physiol 1978; 44, 840–848.
Gomes-Marcondes MC, Tisdale MJ. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett. 2002; 180 69–74.
Gorini M, Ginanni R, Spinelli A, Duranti R, Andreotti L, Scano G. Inspiratory muscle strength and respiratory drive in patients with rheumatoid arthritis. Am Rev Respir Dis. 1990; 142, 289–294.
Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000; 71, 1033–1047.
Gosker HR, Lencer NH, Franssen FM, van der Vusse GJ, Wouters EF, Schols AM. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest. 2003; 123, 1416–1424
Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996; 153, 976–980.
Greiwe JS, Cheng B, Rubin DC, Yarasheski KE, Semenkovich CF. Resistance exercise decreases skeletal muscle tumor necrosis factor alpha in frail elderly humans. FASEB J 2001; 15, 475–482.
Griggs G, Findley L, Suratt P, Esau S, Wilhoit S, Rochester D. Plonged relaxation rate of inspiratory muscles in patients with sleep apnea. Am Rev Respir Dis 1989;140, 706–710.
Grimby G, Saltin B. The ageing muscle. Clin Physiol 1983; 3, 209–218.
Guilleminault C, Stoohs R, Quera-Salva MA. Sleep-related obstructive and non-bstructive apneas and neurologic disorders. Neurology 1992; 42 (suppl 6), 53–60.
Gustafson T, Boman K, Rosenhall L, Sandstrom T, Wester PO. Skeletal muscle magnesium and potassium in asthmatics treated with oral beta 2-agonists. Eur Respir J 1996; 9, 237–240.
Hall-Angeras M, Angeras U, Zamir O, Hasselgren PO, Fischer JE. Interaction between corticosterone and tumor necrosis factor simulated protein breakdown in rat skeletal muscle similar to sepsis. Surgery 1990; 108, 460–466.
Hambrecht R, Fiehn E, Yu J, et al. Effects of endurance training on mitochondrial ultrastructure and fiber type distribution in skeletal muscle of patients with stable chronic heart failure. J Am Coll Cardiol 1997; 29, 1067–1073.
Hamilton AL, Killian KJ, Summers E, Jones NL. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995; 52, 2021–2031.
Harley HG, Brook JD, Rundle SA et al. Expansion of un unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992; 355, 547–548.
Harridge SD, Magnusson G, Gordon A. Skeletal muscle contractile characteristics and fatigue resistance in patients with chronic heart failure. Eur Heart J 1996; 17, 896–901.
Harrington D, Anker SD, Chua TP, et al. Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. J Am Coll Cardiol 1997; 30, 1758–1764.
Hernandez N, Orozco-Levi M, Belalcazar V et al. Dual morphometrical changes of the deltoid muscle in patients with COPD. Respir Physiol Neurobiol 2003; 134, 219–229.
Hoffman EP, Brown RH, Kunkel LM. Dystrophin: The product of the Duchennne muscular dystrophy locus. Cell 1987; 51, 919.
Hoffmann M, Bybee K, Accurso V, Somers VK. Sleep apnea and hypertension. Minerva Med 2004; 95, 281–290.
Holliday R. Reflections in mutation research. Somatic mutation and ageing. Mutat Res 2000; 463, 173–178.
Howard RS, Wiles CM, Hirsch NP, Loh L, Spencer GT, Newsom-Davis J. Respiratory involvement in multiple sclerosis. Brain 1992; 115, 479–494.
Hughes RL, Katz H, Sahgal V, Campbell JA, Hartz R, Shields TW. Fiber size and energy metabolites in five separate muscles from patients with chronic obstructive lung diseases. Respiration 1983; 44, 321–328.
Hussain SNA, Simkus G, Roussos C. Respiratory muscle fatigue: A cause of ventilatory failure in septic shock. J Appl Physiol 1985; 58, 2033–2040.
Hussain SNA. Respiratory muscle dysfunction in sepsis. Mol Cell Biochem 1998; 179, 125–134.
Jackson MJ, Edwards RH. Free radicals and trials of antioxidant therapy in muscle diseases. Adv Exp Med Biol 1990; 264, 485–491.
Jackson MJ, O’Farrel S. Free radicals and muscle damage. Br Med Bull 1993; 49, 630–641.
Jakobsson F, Borg K, Edstrom L. Fibre-type composition, structure, and cytoskeletal protein location of fibres in anterior tibialis muscle. Comparison between young adults and physically active aged humans. Acta Neuropathol (Berl) 1990a; 459–468.
Jakobsson P, Jorfeldt L, Brundin A. Skeletal muscle metabolites and fiber types in patients with advanced chronic obstructive pulmonary disease (COPD), with and without chronic respiratory failure. Eur Respir J 1990b; 3, 192–196.
Jakobsson P, Jordfelt L, Henriksson. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995; 151, 374–377.
Jardim J, Mayer A, Camelier A. Respiratory muscles and pulmonary rehabilitation in asthmatic patients. Arch Bronconeumol 2002; 38, 181–188.
Jerusalem F, Rakusa M, Engel AG et al. Morphometric analysis of skeletal muscle capillary ultraestructure in inflammatory myopathies. J Neurol Sci 1974; 23, 391–402.
Jimenez M, Gea J, Aguar MC et al. Capillary density and respiratory function in the external intercostal muscle. Arch Bronconeumol 1999; 35, 471–476.
Johnson P, Hammer JL. Cardiac and skeletal muscle enzyme levels in hypertensive and aging rats. Comp Biochem Physiol 1993; 104, 63–67.
Kaminski HJ, Ruff RL. Endocrine myopathies (hyper- and hypofunction of adrenal, thyroid, pituitary, and parathyroid glands, and iatrogenic corticosteroid myopathy. In: Myology. Engel AG and Franzini-Armstrong C eds. New York 1994, pp 1726–1733.
Kaplan LM, Hollander D. Respiratory dysfuntion in amyothrophic lateral sclerosis. In: Respiratory dysfunction in neuromuscular disease. Clin Chest Med. Fanburg BL and Sicilian L eds. WB Saunders Company. Philadelphia 1994, pp 675–681.
Kemp G, Thompson C, Stratton J et al. Abnormalities in exercising skeletal muscle in congestive heart failure can be explained in terms of decreased mitochondrial ATP synthesis, reduced metabolic efficiency, and increased glycogenolysis. Heart 1996; 76, 35–41.
Khawli F, Reid MB. N-acetylcysteine depresses contractile function and inhibits fatigue of diaphragm in vitro. J Appl Physiol 1994; 77, 317–324.
Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJM. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow obstruction. Am Rev Respir Dis 1992; 146, 935–940.
Kimoff J, Cheong T, Olha A, Charbonneau M, Levy R, Cosio M et al.. Mechanisms of apnea termination in obstructive sleep apnea. Am J Respir Crit Care Med 1994; 149, 707–14.
Kirchberger M. Excitation and contraction of skeletal muscle. In West JB (ed) Physiological Basis of Medical Practice. Williams & Wilkins, Baltimore 1991, MD, pp. 62–102.
Kirkendall DT, Garrett WE Jr. The effects of aging and training on skeletal muscle. Am J Sports Med 1998; 26, 598–602.
Kleine TO. Glycolytic and gluconeogenetic enzyme activities in skeletal muscle of differently aged persons. Acta Gerontol 1976; 6, 489–494.
Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298, 249–258.
Kobzik L, Reid MB, Bredt DS, Stamler JS. Nitric oxide in skeletal muscle. Nature 1994; 372, 546–548.
Krause KM, Moody MR, Andrade FH, Addison AT, Miller CC III, Kobzik L, Reid MB. Peritonitis causes diaphragm weakness in rats. Am J Respir Crit Care Med 1998; 157, 1277–1282.
Lacomis D, Giuliani M, Van Cott A et al. Acute myopathy of intensive care: clinical, electromyographic and pathological aspects. Ann Neurol 1996; 40, 645–654.
Lampert E, Mettauer B, Hoppeler H, Charloux A, Charpentier A, Lonsdorfer J. Structure of skeletal muscle in heart transplant recipients. J Am Coll Cardiol 1996; 28:980–984.
Lands LC, Heigenhauser GJ, Jones NL. Respiratory and peripheral muscle function in cystic fibrosis. Am Rev Respir Dis 1993; 147, 865–869.
Lavietes MH, Grocela JA, Maniatis T, Potulski F, Ritter AB, Sunderam G. Inspiratory muscle strenght in asthma. Chest 1988; 93, 1043–1048.
Lawler JM, Cline CC, Hu Z, Coast JR. Effect of oxidant challenge on contractile function of the aging rat diaphragm. Am J Physiol 1997; 272, E201–E207.
Le Bourdelles G, Viires N, Boczkowski J et al. Effects of mechanical ventilation on diaphragmatic contractile properties in rats. Am J Respir Crit Care Med 1994; 149, 1539–1544.
Leeuwenburgh C, Hansen P, Sahish A, Holloszy JO, Heinecke JW. Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats. Am J Physiol 1998; 274, R453–R461.
Leon A, Boczkowski J, Dureuil B, Desmonts JM, Aubier M. Effects of endotoxic shock on diaphragmatic function in mechanically ventilated rats. J Appl Physiol 1992; 72, 1466–1472.
Levine S, Kaiser L, Leferovich J, Tikunov B. Cellular adaptations in the diaphragm in chronic obstructive pulmonary disease. N Engl J Med 1997; 337, 1799–1806.
Lexell J, Taylor CC, Sjöström M. What is the cause of the ageing atrophy? Total number, size, and proportion of different fiber types studied in the whole vastus lateralis muscle from 15 to 83 year-old men. J Neurol Sci 1986; 84, 275–294.
Lexell J, Downham D. What is the effect of ageing on type 2 muscle fibres? J Neurol Sci 1992; 107, 250–251.
Lieu F, Powers SK, Herb RA, Criswell D, Martin D, Wood C, Stainsby W, Chen CL. Exercise and glucocorticoid-induced diaphragmatic myopathy. J Appl Physiol 1993; 75, 763–771.
Lindsay DC, Lovegrove CA, Dunn MJ, et al. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 1996; 17, 1239–1250.
Lipkin DP, Jones DA, Round JM, Poole Wilson PA. Abnormalities of skeletal muscle in patients with chronic heart failure. Int J Cardiol 1988; 18, 187–195.
Llesuy S, Evelson P, Gonzalez B, Peralta JG, Carreras MC, Poderoso JJ, Boveris A. Oxidative stress in muscle and liver of rats with septic syndrome. Free Radic Biol Med 1994; 16, 445–451.
Lloreta J, Orozco-Levi M, Gea J, Broquetas J. Selective diaphragmatic mitochondrial abnormalities in a patient with marked airflow obstruction. Ultrastruct Pathol 1996; 20, 67–71.
Llovera M, Garca-Martnez C, Agell N, Marzábal M, López-Soriano FJ, Argilés JM. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett 1994; 338, 311–318.
Llovera M, Garca-Martnez C, Agell N, López-Soriano FJ, Argilés JM. Muscle waisting associated with cancer cachexia is linked to an important activation of the ATP-dependent ubiquitin-mediated proteolysis. Int J Cancer 1995; 61, 138–141.
Llovera M, Carbó N, López-Soriano FJ, Garca-Martnez C, Busquets S, Alvarez B, Agell N, Costelli P, López-Soriano FJ, Celada A, Argilés JM. Different cytokines modulate ubiquitin-gene expression in rat skeletal muscle. Cancer Lett 1998; 133, 83–87.
Lovis C, Mach F, Unger PF, Bouillie M, Chevrolet JC. Elevation of creatine kinase in acute severe asthma is not of cardiac origin. Intensive Care Med 2001; 27, 528–533.
Lowe DA, Degens H, Chen KD, Always SE. Glyceraldehyde-3-phosphate dehydrogenase varies with age in glycolytic muscles of rats. J Gerontol 2000; 55, B160–B164.
Lynn DJ, Woda RP, Mendell JR. Respiratory dysfunction in muscular dystrophy and other myopathies. In: Respiratory dysfunction in neuromuscular disease. Clin Chest Med. Fanburg BL and Sicilian L eds. WB Saunders Company. Philadelphia 1994, pp 661–674.
Maines MD. Heme oxygenase; function, multiplicity, regulatory mechanisms and clinical implications. FASEB J 1988; 2, 2557–2568.
Mainwood GW, Renaud JM. The effect of acid-base balance on fatigue of skeletal muscle. Can J Physiol Pharmacol 1985; 63, 403–416.
Maltais F, Leblanc P, Simard C, Jobin J, Berubé C, Bruneau J, Carrier L, Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154, 442–447.
Mancini DM, Coyle E, Coggan A, et al. Contribution of intrinsic skeletal muscle changes to 31P NMR skeletal muscle metabolic abnormalities in patients with chronic heart failure. Circulation 1989; 80, 1338–1346.
Mancini DM, Henson D, LaManca J, Levine S. Respiratory muscle function and dyspnea in patients with chronic congestive heart failure. Circulation 1992; 86, 909–918.
Martyn J, Powell E, Shore S, Emrich J, Engel LA. The role of respiratory muscles in the hyperinflation of bronchial asthma. Am Rev Respir Dis 1980; 121, 441–447.
Matsubara S, Okada T, Yoshida M. Mitochondrial changes in acute myopathy after treatment of respiratory failure with mechanical ventilation (acute relaxant-steroid myopathy). Acta Neuropathol 1994; 88, 475–478.
Mckenzie DK, Gandevia SC. Strenght and endurance of inspiratory and limb muscles in asthma. Am Rev Respir Dis 1986; 134, 999–1004.
McComas AJ. Skeletal muscle: form and function. Champaign, IL: Human Kinetics, 1996.
McCoubrey WK, Ewing JF, Maines MD. Human heme oxygenase-2: characterization and expression of a full-length cDNA and evidence suggesting that the two HO-2 transcripts may differ by choice of polyadenylation signal. Arch Biochem Biophys 1992; 295, 13–20.
McCoubrey WK, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 1997; 247, 725–732.
McParland C, Resch EF, Krishnan B, Wang Y, Cujec B, Gallagher CG. Inspiratory muscle weakness in chronic heart failure: role of nutrition and electrolyte status and systemic myopathy. Am J Respir Crit Care Med 1995; 151, 1101–1107.
Mehta S, Nelson DL, Klinger JR, Buczko GB, Levy MM. Prediction of post-extubation work of breathing. Crit Care Med 2000; 28, 1341–1346.
Mier-Jedrzejowicz AK, Brophy C, Green M. Respiratory muscle function in myasthenia gravis. Am Rev Respir Dis 1988; 138, 867–873.
Miller MM. Current trends in the primary care management of chronic congestive heart failure. Nurse Pract 1994; 19, 64–70.
Miyagi K, Asanoi H, Ishizaka S, et al. Importance of total leg muscle mass for exercise intolerance in chronic heart failure. Jpn Heart J 1994; 35, 15–26.
Mizuno M. Human respiratory muscles: fibre morphology and capillary supply. Eur Respir J 1991; 4, 587–601.
Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43, 109–142.
Montes de Oca M, Rassulo J, Celli B. Respiratory muscle and cardiopulmonary function during exercise in very severe COPD. Am J Respir Crit Care Med 1996; 154, 1284–1289.
Murphy TD, Gibson R, Standaert TA, Woodrum DE. Diaphragmatic failure during group streptococcal sepsis in piglets: the role of thromboxane A2. J Appl Physiol 1995; 78(2), 491–498.
Myers J, Salleh A, Buchanan N, et al. Ventilatory mechanisms of exercise intolerance in chronic heart failure. Am Heart J 1992; 124, 710–719.
Nava S, Bruschi C, Franchia C, Fezicetti G, Callezsri G, Ambrosino N.. Acute treatment with corsticosteroids (CS) alters respiratory (RM) and skeletal muscles (SM) function in humans. Eur Respir J 1996; 9 (suppl), S298.
Ninane V, Rypens F, Yernault J, De Troyer A. Abdominal muscle use during breathing in patients with chronic airflow obstruction.Am Rev Respir Dis 1992; 146, 16–21.
Noguera A, Sala E, Pons AR, Iglesias J, MacNee W, Agusti AG. Expression of adhesion molecules during apoptosis of circulating neutrophils in COPD. Chest 2004; 125, 1837–1842.
Nowinski A, Gea J, Bielew P et al. Structure of the external intercostal muscle in patients with obstructive sleep apnea syndrome (OSAS). Eur Respir J 2001; 18 (suppl 33), 178s.
Oh-ishi S, Toshinai K, Kizaki , Haga S, Fukuda K, Nagata N, Ohno H. Effects of aging and/or training on antioxidant enzyme system in diaphragm of mice. Respir Physiol 1996; 105, 195–202.
Orozco-Levi M, Gea J, Monells J, Arán X, Aguar MC, Broquetas JM. Activity of latissimus dorsi muscle during inspiratory thershold loads. Eur Respir J 1995a; 8, 441–445.
Orozco-Levi M, Gea J, Sauleda J, Corominas JM, Minguella J, Arán X, Broquetas JM. Structure of the latissimus dorsi muscle and respiratory function. J Apply Physiol 1995b; 78, 1132–1139.
Orozco-Levi M, Gea J, Lloreta J et al. Subcellular adaptation of the human diaphragm in Chronic Obstructive Pulmonary Disease. Eur Respir J 1999; 13, 371–378.
Orozco-Levi M, Lloreta J, Minguella J, Serrano S, Broquetas J, Gea J. Injury of the human diaphragm associated with exertion and COPD Am J Respir Crit Care Med 2001; 164, 1734–1739.
Pansarasa O, Castagna L, Colombi B, Vecchiet J, Felzani G, Marzatico F. Age and sex differences in human skeletal muscle: role of reactive oxygen species. Free Rad Res 2000; 33, 287–293.
Parish JM, Somers VK. Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 2004; 79, 1036–1046.
Pascual J, Gea J, Aran X et al. Early markers of pulmonary dysfunction in amyotrophic lateral sclerosis. J Neurol Scienc 1990; 98 (suppl), 341.
Peralta JG, Llesuy S, Evelson P, Carreras MC, Gonzalez B, Poderoso JJ. Oxidative stress in skeletal muscle during sepsis in rats. Cir Shock 1993; 39, 153–159.
Peress L, Sybrecht G, Macklem PT. The mechamism of increase in total lung capacity during acute asthma. Am Rev Respir Dis 1986; 134, 994–1004.
Picado C, Fiz JA, Montserrat JM et al. Respiratory and skeletal muscle function in steroid-dependent bronchial asthma. Am Rev Respir Dis 1990; 141, 14–20.
Plotz PH, Dalakas M, Leff RL et al. Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis, and related disorders. Ann Intern Med 1989; 111, 143–157.
Polkey MI, Moxham J. Clinical aspects of respiratory muscle dysfunction in the critically ill. Chest 2001; 119, 926–939.
Pouw EM, Schols AMWJ, Vusse van der GJ, Wouters EFM. Elevated inosine monophosphate levels in resting muscle of patients with stable COPD. Am J Respir Crit Care Med 1998; 157, 453–457.
Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993; 33, 137–151.
Rall LC, Rosen CJ, Dolnikowski G, Hartman WJ, Lundgren N, Abad LW, Dinarello CA, Roubenoff R. Protein metabolism in rheumatoid arthritis and aging. Effects of muscle strength training and tumor necrosis factor alpha. Arthritis Rheum 1996; 39, 1115–1124.
Ramirez A, Orozco-Levi M, Barreiro E et al. Expiratory muscle endurance in chronic obstructive pulmonary disease. Thorax 2002; 57, 132–136.
Ramsay DA, Zochodne DW, Robertson DM, Nag S, Ludwin SK. A syndrome of acute severe muscle necrosis in intensive care unit patients. J Neuropathol Exp Neurol 1993; 52, 387–398.
Rankin GB. Extraintestinal and systemic manifestations of inflammatory bowel disease. Med Clin North Am 1990; 74, 39–50.
Rannels SR, Rannels DE, Pegg AE, Jefferson LS. Glucocorticoid effects on peptide-chain initiation in skeletal muscle and heart. Am J Physiol 1978; 235, E134–E139.
Reid MB, Haack KE, Franchek KM, Valberg PA, Kobzik L, West MS. Reactive oxygen in skeletal muscle: I. Intracellular oxidant kinetics and fatigue in vitro. J Appl Physiol 1992; 73, 1797–1804.
Reid MB, Khawli FA, Moody MR. Reactive oxygen in skeletal muscle.III. Contractility of unfatigued muscles. J Appl Physiol 1993; 75, 1081–1087.
Reid MB, Li YP. Cytokines and oxidative signaling in skeletal muscle. Acta Physiol Scand 2001; 171, 225–232.
Reid MB, Durham WJ. Generation of reactive oxygen and nitrogen species in contracting skeletal muscle. Ann NY Acad Sci 2002; 959, 108–116.
Reznick AZ, Steinhagen-Thiessen E, Silbermann M. Acid and alkaline phosphatase activity in skeletal muscle of aging mice and following prolonged training program. Trends Biomed Gerontol 1988; 1, 91–94.
Richmonds CR, Boonyapisit K, Kusner LL, Kaminski HJ. Nitric oxide synthase in aging rat skeletal muscle. Mech Ageing Dev 1999; 109, 177–189.
Rochester DF, Braun NMT, Arora NS. Respiratory muscle strength in chronic obstructive pulmonary disease. Am Rev Respir Dis 1979; 119, 151–154.
Rochester DF, Arora NS. The respiratory muscles in asthma. In: Lavietes MH, Reichman LB, editors. Diagnostic aspects and management of asthma. Norwalk: Purdue-Frederick CO, 1981.
Rochester DF, Braun NMT. Determinants of maximal inspiratory pressure in chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132, 42–47.
Roubenoff R, Roubenoff RA, Cannon JG, Kehayias JJ, Zhuang H, Dawson-Hughes B, Dinarello CA, Rosenberg IH. Rheumatoid cachexia: cytokine-driven hypermetaboolism accompanying reduced body cell mass in chronic inflammation. J Clin Invest 1994; 93, 2379–2386.
Safadi A, Livne E, Reznick AZ. Characterization of alkaline and acid phosphatase from skeletal muscle of young and old rats. Arch Gerontol Geriatr 1997; 24, 183–196.
Sala E, Roca J, Marrades RM, Alonso J, Gonzalez de Suso JM, Moreno A, Barberá JA, Nadal J, de Jover L, Rodrguez-Roisn R, Wagner PD. Effect of endurance training on skeletal muscle bioenergetic in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159, 1726–1734.
Salvarani C, Vlachonikolis IG, van der Heijde DM et al. Musculoskeletal manifestations in a population-based cohort of inflammatory bowel disease patients. Scand J Gastroenterol 2001; 36, 1307–1313.
Sato T, Akatsuka H, Kito K, Tokoro Y, Tauchi H, Kato K. Age changes in size and number of muscle fibers in human minor pectoral muscle. Mech Ageing Dev 1984; 28, 99–109.
Sato Y, Asoh T, Honda Y, Fujimatso Y, Higuchi I, Oizumi K. Morphological and histochemical evaluation of biceps muscle in patients with chronic pulmonary emphysema manifesting generalized emaciation. Eur Neurol 1997; 37, 116–121.
Satta A, Migliori GB, Spanevello A et al. Fibre types in skeletal muscles of chronic obstructive pulmonary disease patients related to respiratory function and exercise tolerance. Eur Respir J 1997; 10, 2853–2860.
Sauleda J, Garcia-Palmer FJ, Tarraga S, Maimo A, Palou A, Agusti AG. Skeletal muscle changes in patients with obstructive sleep apnoea syndrome. Respir Med 2003; 97, 804–810.
Schaufelberger M, Eriksson BO, Grimby G, Held P, Swedberg K. Skeletal muscle fiber composition and capillarization in patients with chronic heart failure: relation to exercise capacity and central hemodynamics. J Card Fail 1995; 1, 267–272.
Schols A, Mostert R, Soeters PB, Wouters EF. Body composition and exercise Performance in patients with chronic obstructive pulmonary disease. Thorax 1991a; 46, 695–699.
Schols A, Wousters E, Soeters P, Westertep K. Body composition by bioelectrical impedance analysis compared to deterium dilution and skinfold anthropometry in patients xith chronic obstructive pulmonary disease. Am J Clin Nutr 1991b; 53, 421–424.
Schols A, Buurman W, van den Brekel S et al. Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 1996; 51, 819–824.
Schols A, Creutzberg E, Buurman W, Campfield L, Saris W, Wouters E. Plasma leptin is related to proinflammatory status and dietary intake in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160, 1220–1226.
Schmidt FR, Cooper NS, Ziff M et al. Arteritis in rheumatoid arthritis. Am J Med 1961; 30, 56–83.
Severgnini S, Lowenthal DT, Millard WJ, Simmen FA, Pollock BH, Borst SE. Altered IGF-I and IGFBPs in senescent male and female rats. J Gerontol 1999; 54, B111–B115.
Shephard RJ. Exercise for patients with congestive heart failure. Sports Med 1997; 23, 75–92.
Shindoh C, DiMarco A, Nethery D, Supinski G. Effect of PEG-superoxide dismutase on the diaphragmatic response to endotoxin. Am Rev Respir Dis 1992; 145, 1350–1354.
Shoji S, Takagi A, Sugita H, Toyokura Y. Muscle glycogen metabolism in steroid-induced myopathy of rabbits. Exp Neurol 1974; 45, 1–7.
Simard C, Maltais F, Leblanc P, Simard PM, Jobin J. Mitochondrial and capillarity changes in vastus lateralis muscle of COPD patients: electron microscopy study. Med Sci Sports Exerc 1996; 28, S95.
Similowski Th, Yan S, Gaithier AP, Macklem PT. Contractile properties of the human diaphragm during chronic hyperinflation. N Eng J Med 1991; 325, 917–923.
Spiers S, McArdle F, Jackson MJ. Aging-related muscle dysfunction: failure of adaptation to oxidative stress? Ann NY Acad Sci 2000; 908, 341–343.
Spizer AR, Giancarlo T, Mahler L. Nueromuscular causes of prolonged ventilator dependency. Muscle Nerve 1992; 15, 682–686.
Stamler JS, Meissner G. Physiology of nitric oxide in skeletal muscle. Physiol Rev 2001; 81, 209–237.
Steele IC, Moore A, Nugent AM, Riley MS, Campbell NPS, Nicholls DP. Non-invasive measurement of cardiac output and ventricular ejection fractions in chronic cardiac failure: relationship to impaired exercise tolerance. Clin Sci 1997; 93, 195–203.
Stratton JR, Kemp GJ, Daly RC, Yacoub M, Rajagopalan B. Effects of cardiac transplantation on bioenergetic abnormalities of skeletal muscle in congestive heart failure. Circulation 1994; 89, 1624–1631.
Stryer L. Biochemistry. New York: WH Freeman and Company, 1988.
Sullivan MJ, Green HJ, Cobb FR. Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. Circulation 1990; 81, 518–527.
Sullivan MJ, Green HJ, Cobb FR. Altered skeletal muscle metabolic response to exercise in chronic heart failure. Relation to skeletal muscle aerobic enzyme activity. Circulation 1991; 84, 1597–1607.
Sullivan MJ, Hawthorne MH. Exercise intolerance in patients with chronic heart failure. Prog Cardiovasc Dis 1995; 38, 1–22.
Supinski G, Nethery D, DiMarco A. Effect of free radical scavengers on endotoxin-induced respiratory muscle dysfunction. Am Rev Respir Dis 1993; 148, 1318–1324.
Supinski G, Nethery D, Stofan D, DiMarco A. Comparison of the effects of endotoxin on limb, respiratory, and cardiac muscles. J Appl Physiol 1996; 81, 1370–1378.
Tada H, Kato H, Misawa T, et al. 31P-nuclear magnetic resonance evidence of abnormal skeletal muscle metabolism in patients with chronic lung disease and congestive heart failure. Eur Respir J 1992; 5, 163–169.
Tein I. Metabolic myopathies. Semin Pediatr Neurol 1996; 3, 59–98.
Teitelbaum JS, Borel CO. Respiratory dysfunction in Guillain-Barré Syndrome. In: Respiratory dysfunction in neuromuscular disease. Clin Chest Med. Fanburg BL and Sicilian L eds. WB Saunders Company. Philadelphia 1994, pp 705–714.
Teixeira A, Cherin P, Demoule A, Levy-Soussan M, Straus C, Verin E, Zelter M, Derenne JP, Herson S, Similowski T. Diaphragmatic dysfunction in patients with idiopathic inflammatory myopathies. Neuromuscul Disord 2005; 15, 32–39.
Tenhunen R, Marver HS, Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proc Natl Acad Sci USA 1968; 61, 748–755.
Tikunov B, Levine S, Mancini D. Chronic congestive heart failure elicits adaptations of endurance exercise in diaphragmatic muscle. Circulation 1997; 95, 910–916.
Tritschler HJ, Bonilla E, Lombes A et al. Differential diagnosis of fatal and benign cytochorme c oxidase-deficient myopathies of infancy: An immunohistochemical approach. Neurology 1991; 41, 300–305.
Tsushima K, Koyama S, Ueno M, Fujimoto K, Ichiyoshi T, Takei Y, Hanyu N, Kubo K. Rhabdomyolysis triggered by an asthmatic attack in a patient with McArdle disease. Intern Med 2001; 40, 131–134.
Van der Vliet A, Eiserich JP, Shigenaga MK, Cross CE. Reactive nitrogen species and tyrosine nitration in the respiratory tract: Epiphenomena or a pathobiologic mechanism of disease? Am J Respir Crit Care Med 1999; 160, 1–9.
Van der Walt JD, Swash M, Leake J et al. The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve 1987; 10, 272–281.
Vilardell M, Font J. Systemic Disorders. In: Internal Medicine. Rozman C, Cardellach F eds. Elsevier. Madrid 2004, pp 1091–1140.
Vincken WG, Gauthier SG, Dollfuss RE, Hanson RE, Darauay CM, Cosio MG. Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med 1984; 311, 438–442.
Voigt E, Griga T, Tromm A, Henschel MG, Vorgerd M, May B. Polymyositis of the skeletal muscles as an extraintestinal complication in quiescent ulcerative colitis. Int J Colorectal Dis 1999; 14, 304–307.
Waclawik AJ, Sufit RL, Beinlich BR, Schutta HS. Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuronium. Neuromuscul Disord 1992; 2, 19–26.
Warren S. The immediate causes of death in cancer. Am J Med Sci 1932; 184, 610–615.
Welle S, Thornton C, Statt M. Myofibrillar protein synthesis in young and old human subjects after three months of resistance training. Am J Physiol 1995; 268, E422–E427.
Whittom F, Jobin J, Simard PM, LeBlanc P, Simard C, Bernard S, Belleau R, Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in COPD patients. Med Sci Sports Exerc 1998; 30, 1467–1474.
Wiedemann HP, Matthway RA. Pulmonary manifestations of the collagen vascular diseases. Clin Chest Med 1989; 10, 677–722.
Wilcox PG, Stein HB, Clarke SD et al. Phrenic nerve function in patients with diaphragmatic weakness and systemic lupus erythematosus. Chest 1988; 93, 352–358.
Wilcox PG, Paré PD, Road JD, Fleetham JA.. Respiratory muscle function during obstructive sleep apnea. Am Rev Respir Dis 1990;142, 533–9.
Wilcox PG, Wakai Y, Walley KR, Cooper DJ, Road J. Tumor necrosis factor α decreases in vivo diaphragm contractility in dogs. Am J Respir Crit Care Med 1994; 150, 1368–1373.
Williams TJ, Snell GI. Early and long-term functional outcomes in unilateral, bilateral, and living-related transplant recipients. Clin Chest Med 1997; 18, 245–257.
Wilson JR, Mancini DM. The mechanism of extertional fatigue in heart failure. Cardioscience 1990; 1, 13–17.
Wood PH. Appreciating the consequences of disease: the international classification of impairments, disabilities, and handicaps. WHO Chron 1980; 34, 376–380.
Yaggi H, Mohsenin V. Obstructive sleep apnoea and stroke. Lancet Neurol 2004; 3, 333–342.
Zarzhevsky N, Carmeli E, Fuchs D, Coleman R, Stein H, Reznick AZ. Recovery of muscles of old rats after hindlimb immobilization by external fixation is impaired compared with those of young rats. Exp Gerontol 2001; 36, 125–140.
Zattara-Hartmann MC, Badier M, Guillot C, Tomei C, Jammes Y. Maximal force and endurance to fatigue of respiratory and skeletal muscles in chronic hypoxemic patients: the effects of oxygen breathing. Muscle Nerve 1995; 18, 495–502.
Zhu E, Petroff B, Gea J, Comtois N, Grassino A. Diaphragm muscle injury after inspiratory resistive breathing. Am J Respir Crit Care Med 1997; 155, 1110–1116.
Zulueta JJ, Fanburg BL. Respiratory dysfunction in Myasthenia Gravis. In: Respiratory dysfunction in neuromuscular disease. Clin Chest Med. Fanburg BL and Sicilian L eds. WB Saunders Company. Philadelphia 1994, pp 683–691.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer
About this chapter
Cite this chapter
Gea, J., Barreiro, E., Orozco-Levi, M. (2006). Skeletal Muscle Adaptations to Disease States. In: Bottinelli, R., Reggiani, C. (eds) Skeletal Muscle Plasticity in Health and Disease. Advances in Muscle Research, vol 2. Springer, Dordrecht. https://doi.org/10.1007/1-4020-5177-8_11
Download citation
DOI: https://doi.org/10.1007/1-4020-5177-8_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-5176-0
Online ISBN: 978-1-4020-5177-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)